SLC7A5 and thyroid cancer: We found that miR-126-3p overexpression significantly decreased luciferase activity as compared to the negative control (Fig 5D), suggesting that miR-126-3p directly targets the 3′-UTR region of ADAM9 and SLC7A5 in thyroid cancer cells.